Innovative Mucosal Vaccine Formulations Against Influenza A Virus Infections

Innovative Mucosal Vaccine Formulations Against Influenza A Virus Infections

Despite efforts made to develop efficient preventive strategies, infections with influenza A viruses (IAV) continue to cause serious clinical and economic problems. Current licensed human vaccines are mainly inactivated whole virus particles or split-virion administered via the parenteral route. The...

Full description

Bibliographic Details
Main Authors: Cynthia Calzas, Christophe Chevalier
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-07-01
Series:Frontiers in Immunology
Subjects:
influenza A virus
mucosal vaccines
adjuvant
delivery systems
intranasal immunization
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2019.01605/full

Internet

https://www.frontiersin.org/article/10.3389/fimmu.2019.01605/full

Similar Items